Please assess the completion status of the following clinical trial:

Trial Title: Safety and Effectiveness of Taking Choline Supplements During Pregnancy for Improving Infant Brain Development

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Pregnant~* Between 10 and 18 weeks gestational age~* Healthy~* Diagnosis of psychosis~Exclusion Criteria:~* Use of any tobacco or nicotine product~* Drinks more than 1 alcoholic drink per day~* Use of illicit drugs~* History of trimethylaminuria~* History of kidney disease~* History of liver disease~* History of pre-pregnancy diabetes~* History of Parkinson's disease~* History of fetal death, fetal/infant congenital malformation, or fetal/infant genetic abnormality~* Evidence of noncompliance to study medication

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: PLACEBO_COMPARATOR): Participants will take placebo
- 2 (Type: ACTIVE_COMPARATOR): Participants will take choline

Based on this trial design, predict the completion outcome and termination type (if applicable).